Ultra-sensitive dual-responsive Zn(II)-MOF fluorescent probe: Rapid recognition of cinoxacin and vitamin B₂ in artificial urine and saliva matrices
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2027
DOI: 10.1016/j.saa.2026.128657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2027. Verfasst von Kaimin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Chiral Functional Substance Research and Application, School of Chemistry & Environment, Yunnan Minzu University, Kunming, Y…. Hauptthemen laut MEDLINE: Zinc, Fluorescent Dyes, Saliva, Riboflavin. Die Arbeit nennt 67 Literaturangaben. Gefördert von: Yunnan Provincial Natural Science Foundation.
Abstract (Originalsprache)
This study successfully synthesized a new zinc-based metal-organic framework material {[Zn(qdda)(bpy)₀.₅]·3H₂O} (Zn-MOF) by the solvothermal method and systematically investigated its performance as a fluorescent material for the simultaneous sensing of the antibacterial drug Cinoxacin (CNX) and Vitamin B₂ (VB₂). The structure, morphology, and composition of the material were comprehensively characterized by single-crystal X-ray diffraction, powder X-ray diffraction (PXRD), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), and Fourier transform infrared spectroscopy (FT-IR). Fluorescence experiments demonstrated that the Zn-MOF demonstrates significant selectivity and sensitivity toward both CNX and VB₂, with detection limits of 9.2 nM and 24 nM, separately, a rapid response (within 60 s), as well as excellent anti-interference ability and recyclability. The observed fluorescence quenching was attributed to a synergistic mechanism involving competitive absorption (CA), resonance energy transfer (RET), and photoinduced electron transfer (PET). In a simulated saliva and urine environment, the material showed satisfactory spike recovery rates for CNX and VB₂, confirming its reliability in practical sample detection. This work opens a new avenue for developing high-performance MOF-based fluorescent sensors. Such sensors show great potential for the simultaneous detection of two analytes within complex biological environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Chiral Functional Substance Research and Application, School of Chemistry & Environment, Yunnan Minzu University, Kunming, Yunnan 650504, PR China.
- School of Forensic Medicine, NHC Key Laboratory of Drug Addiction Medicine, Institute for Engineering Medicine, Kunming Medical University, Kunming, Yunnan 650500, PR China. Electronic address: zrlorg@126.com.
- School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, PR China; College of Modern Biomedical Industry, Kunming Medical Univ…
Förderung
- Yunnan Provincial Natural Science Foundation
Zitieren
APA
Wang, K., Luo, X., Yang, J., Chen, L., Zhang, R., & Ma, Y. (2027). Ultra-sensitive dual-responsive Zn(II)-MOF fluorescent probe: Rapid recognition of cinoxacin and vitamin B₂ in artificial urine and saliva matrices. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2026.128657
Vancouver
Wang K, Luo X, Yang J, Chen L, Zhang R, Ma Y. Ultra-sensitive dual-responsive Zn(II)-MOF fluorescent probe: Rapid recognition of cinoxacin and vitamin B₂ in artificial urine and saliva matrices. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2027. doi:10.1016/j.saa.2026.128657
BibTeX
@article{Wang2027,
author = {Wang, Kaimin and Luo, Xi and Yang, Jing and Chen, Ling and Zhang, Ruilin and Ma, Yulu},
title = {Ultra-sensitive dual-responsive Zn(II)-MOF fluorescent probe: Rapid recognition of cinoxacin and vitamin B₂ in artificial urine and saliva matrices},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2027},
doi = {10.1016/j.saa.2026.128657}
}
EUVIMED